Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) received its original FDA authorization to lower blood sugar in people with type 2 diabetes, yet clinical trials revealed an unexpected benefit: significant body weight reduction. This discovery transformed how healthcare providers view the medication, even though its primary label remains diabetes management. PlexusDx delivers pharmaceutical-grade compounded semaglutide from licensed 503A pharmacies, making precision GLP-1 therapy accessible across all 50 states.
How Semaglutide Causes Weight Loss Without Being Labeled for It
Semaglutide activates GLP-1 receptors in the brain's appetite control centers, specifically the hypothalamus and nucleus accumbens. This activation slows gastric emptying, meaning food stays in the stomach longer and creates prolonged fullness signals. Patients typically eat 20-30% fewer calories naturally without restrictive dieting, because hunger hormones like ghrelin decrease while satiety hormones increase.
The medication also affects dopamine and opioid pathways that regulate food cravings and reward-seeking behavior around eating. Clinical data from the SUSTAIN trials (which followed diabetic patients for up to 2 years) showed average weight losses of 6-15 pounds, with some individuals losing significantly more when combined with lifestyle changes. These results occurred in people taking the drug primarily for blood sugar control, demonstrating that weight reduction happens as a biological consequence of GLP-1 receptor activation, not because the drug was formulated specifically for weight loss.
FDA Approval Status: Why Ozempic and Wegovy Are Technically Different
Ozempic carries FDA approval exclusively for type 2 diabetes management at doses ranging from 0.5 mg to 2.0 mg weekly. Wegovy, which contains the identical active ingredient semaglutide, received separate FDA clearance in 2021 specifically for chronic weight management in adults with obesity or overweight status with weight-related conditions. The distinction exists because each product underwent distinct clinical trials, manufacturing processes, and regulatory pathways, even though the compound itself is chemically identical.
PlexusDx compounded semaglutide injection is prepared by licensed 503A compounding pharmacies using pharmaceutical-grade raw materials, offering the same active compound in a personalized format. Compounded medications are not FDA-approved products themselves, but they are legally manufactured under state pharmacy boards and federal regulations (USP <797> standards) for patients whose medical needs require customization. This approach provides flexible dosing options and consistent pricing—starting at $149 monthly—without insurance dependence or membership fees.
Clinical Evidence: Weight Loss Results From Semaglutide Trials
The SUSTAIN-6 trial followed 3,297 people with type 2 diabetes taking semaglutide 1.0 mg or 2.0 mg weekly for 104 weeks. Participants achieved average weight reductions of 4.5-6.5 kg (10-14 pounds) compared to placebo, alongside improvements in HbA1c (blood sugar control marker). Notably, weight loss continued progressively throughout the study period, indicating that the medication's metabolic effects persist rather than plateau.
The SELECT trial, published in 2023, enrolled 17,604 adults with obesity or overweight plus cardiovascular disease but without diabetes. Participants receiving semaglutide 2.4 mg weekly lost an average of 22 pounds (10% of body weight) over 68 weeks, with 75% achieving at least 5% weight reduction and 50% achieving 15% or greater reduction. These results underscore that semaglutide's weight loss mechanism functions independently of its blood sugar effects, making it a powerful tool for metabolic health across multiple patient populations.
Personalized GLP-1 Therapy: Why Genetic Testing Matters
Not everyone responds identically to semaglutide or other GLP-1 medications. Genetic variations in the GLP1R gene (such as rs6923761), GIPR gene (rs1800437), and metabolic genes like FTO (rs9939609) influence how strongly your body's cells respond to these peptides. Some individuals possess genetic variants that reduce GLP-1 receptor sensitivity, meaning standard doses may produce minimal weight loss, while others have heightened receptor activity and require careful dose escalation to avoid side effects.
PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways across 49 peptides, identifying your unique genetic predispositions to GLP-1 responsiveness, satiety signaling, and fat storage patterns. This $99 add-on test (available after starting treatment) guides your healthcare provider in optimizing compound selection and dosing strategy, transforming weight loss therapy from a one-size-fits-all approach into a precision medicine protocol matched to your biology. Knowledge of these genetic factors enables faster achievement of therapeutic benefit and minimizes trial-and-error medication adjustments.
Cost and Access: How PlexusDx Makes Semaglutide Affordable
Traditional Ozempic and Wegovy prescriptions often require insurance coverage, copayments ranging from $250-$1,000 monthly, or manufacturer savings programs with enrollment delays. PlexusDx compounded semaglutide injection starts at $149 per month with transparent, flat pricing across three commitment tiers—your dose may need to go up, but your price won't. No insurance is required, no membership fees apply, and HSA and FSA accounts can be used for payment, reducing effective out-of-pocket costs for many patients.
PlexusDx serves all 50 states, shipping directly from licensed 503A compounding pharmacies to your home with clinical support from qualified practitioners. The company offers multiple semaglutide formats: compounded injection ($149/mo), oral semaglutide ($249/mo), or combination products like GLP-Squared for patients needing dual-compound therapy. This accessibility model removes geographic and financial barriers, enabling millions of Americans to access the same active pharmaceutical ingredient driving weight loss in clinical trials.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic actually a weight loss drug, or is weight loss just a side effect?
Ozempic's official FDA indication is type 2 diabetes, but semaglutide produces weight loss through direct biological mechanisms (GLP-1 receptor activation reducing appetite and increasing fullness). Wegovy, the semaglutide product FDA-approved specifically for weight management, demonstrates this is not a coincidental side effect but a reliable, dose-dependent therapeutic outcome. PlexusDx compounded semaglutide delivers the same active ingredient for flexible, personalized dosing.
How much weight can I expect to lose with semaglutide?
Clinical trials show average weight losses of 10-22 pounds over 3-6 months, with continued reductions reaching 15-20% of starting body weight when combined with lifestyle modifications. Individual results vary significantly based on genetics, adherence to dose escalation, diet quality, and physical activity—some patients lose 30+ pounds while others lose 5-10 pounds. PlexusDx Precision Peptide Genetic Test helps predict your likely response category by analyzing GLP1R, GIPR, and FTO genetic variants.
Why is PlexusDx compounded semaglutide cheaper than brand-name Ozempic or Wegovy?
Compounded medications bypass brand-name manufacturing and marketing costs, and PlexusDx eliminates insurance intermediaries, membership fees, and copayment structures. Your dose may need to go up as your body adapts, but your price stays flat at $149/month for semaglutide injection—no tiered pricing based on dose strength. Compounded medications are legally manufactured by licensed 503A pharmacies and contain identical pharmaceutical-grade active ingredients.
Are there side effects or safety concerns with compounded semaglutide?
Common side effects include nausea, vomiting, constipation, and fatigue during initial dose escalation—these typically resolve within 1-2 weeks as your body adapts. Rare serious risks include pancreatitis, gallbladder issues, and thyroid C-cell tumors (in animal studies at high doses). PlexusDx compounded semaglutide is prepared under USP <797> standards by licensed 503A pharmacies; your practitioner monitors blood work and symptoms throughout treatment to ensure safety.
What does the PlexusDx Precision Peptide Genetic Test reveal?
This $99 test examines your genetic variants in GLP1R, GIPR, FTO, and MC4R genes plus 10 other metabolic pathways spanning 49 peptides. Results predict whether you'll be a strong GLP-1 responder, require higher doses, or might benefit from dual-compound therapy like GLP-Squared. This precision approach personalizes your weight loss treatment plan, potentially accelerating results and reducing unnecessary medication adjustments.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding Your Ozempic® Pen: A Comprehensive Guide to Doses and Effective Use
What to Avoid While Taking Ozempic for Best Results